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RESEARCH ARTICLE
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Downstream next-generation sequencing (NGS) of the syphilis spirochete
Treponema pallidum subspecies pallidum (T. pallidum) is hindered by low bacterial loads
and the overwhelming presence of background metagenomic DNA in clinical specimens.
In this study, we investigated selective whole-genome ampliﬁcation (SWGA) utilizing multiple displacement ampliﬁcation (MDA) in conjunction with custom oligonucleotides with
an increased speciﬁcity for the T. pallidum genome and the capture and removal of 59-Cphosphate-G-39 (CpG) methylated host DNA using the NEBNext Microbiome DNA enrichment kit followed by MDA with the REPLI-g single cell kit as enrichment methods to
improve the yields of T. pallidum DNA in isolates and lesion specimens from syphilis
patients. Sequencing was performed using the Illumina MiSeq v2 500 cycle or NovaSeq
6000 SP platform. These two enrichment methods led to 93 to 98% genome coverage at
5 reads/site in 5 clinical specimens from the United States and rabbit-propagated isolates,
containing .14 T. pallidum genomic copies/m L of sample for SWGA and .129 genomic
copies/m L for CpG methylation capture with MDA. Variant analysis using sequencing data
derived from SWGA-enriched specimens showed that all 5 clinical strains had the A2058G
mutation associated with azithromycin resistance. SWGA is a robust method that allows
direct whole-genome sequencing (WGS) of specimens containing very low numbers of T.
pallidum, which has been challenging until now.
IMPORTANCE Syphilis is a sexually transmitted, disseminated acute and chronic infection
caused by the bacterial pathogen Treponema pallidum subspecies pallidum. Primary syphilis typically presents as single or multiple mucocutaneous lesions and, if left untreated,
can progress through multiple stages with various clinical manifestations. Molecular studies often rely on direct ampliﬁcation of DNA sequences from clinical specimens; however,
this can be impacted by inadequate samples due to disease progression or timing of
patients seeking clinical care. While genotyping has provided important data on circulating strains over the past 2 decades, WGS data are needed to better understand strain diversity, perform evolutionary tracing, and monitor antimicrobial resistance markers. The
signiﬁcance of our research is the development of an SWGA DNA enrichment method
that expands the range of clinical specimens that can be directly sequenced to include
samples with low numbers of T. pallidum.
KEYWORDS DNA enrichment, Treponema pallidum, metagenomics, syphilis, whole-
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yphilis, caused by Treponema pallidum subspecies pallidum (here referred to as T.
pallidum), is steadily increasing in the United States. In 2019, 38,992 cases (11.9 per
100,000 people) of primary and secondary (P&S) syphilis and 1,870 cases (48.5 per
100,000 live births) of congenital syphilis were reported to the CDC, representing a
167.2% increase in P&S syphilis rates since 2010 and a 291.1% increase in congenital
syphilis since 2015 (1). Penicillin has been the drug of choice for treating all stages of
syphilis; however, azithromycin has been used as an alternative to penicillin for treating early syphilis or contacts of syphilis cases worldwide. Macrolide-resistant T. pallidum strains associated with two mutations (A2508G, A2509G) in the 23S rRNA genes
have since been reported worldwide (2–5). While macrolides are not recommended as
ﬁrst-line treatment in many countries, periodic monitoring is useful to determine the
prevalence of resistant strains (6).
Molecular studies on contemporary T. pallidum strains in the United States remains
challenging due to the limited number of whole genomes sequenced directly from
clinical specimens. Strain diversity has been gleaned from molecular epidemiology
studies, which are based on a few genetic loci but may not be representative of the
entire T. pallidum genome (7–10). In addition, studies have relied primarily on strains
propagated in rabbits or DNA ampliﬁed directly from clinical specimens, because T.
pallidum cannot be grown on routine laboratory medium. However, advances have
been made with in vitro tissue culture and the propagation of T. pallidum in rabbits
from cryopreserved genital lesion specimens, which may make routine culture directly
from clinical specimens a possibility in the near future (11–13).
Metagenomic shotgun sequencing approaches have made signiﬁcant advances in
recent years, with sequence data being used for pathogen detection, whole-genomebased typing, and antimicrobial resistance marker detection, in addition to phylogenetic
analyses (14–16). However, direct whole-genome sequencing (WGS) of T. pallidum from
clinical specimens and rabbit isolates can be problematic due to bacterial genomic DNA
(gDNA) being outweighed by either human or rabbit DNA, respectively. Several DNA
enrichment methods have been described for T. pallidum, including RNA bait capture techniques, methyl-directed enrichment using the restriction nuclease DpnI, and pooled
whole-genome ampliﬁcation (17–22). These methods have generated T. pallidum-speciﬁc
WGS data from over 700 metagenomic samples; however, sequencing specimens with low
numbers of T. pallidum remains challenging. Therefore, new approaches that would enable
sequencing of samples with low bacterial loads are needed. Host DNA removal by 59-Cphosphate-G-39 (CpG) methylated capture and selective whole-genome ampliﬁcation
(SWGA), which allows selective ampliﬁcation of gDNA of the species of interest compared
to host DNA, have been successfully used for enriching bacterial gDNA in metagenomic
samples (23–27); however, these methods have not been applied to T. pallidum.
In this study, we describe a DNA enrichment method based on selective whole-genome ampliﬁcation (SWGA) using multiple displacement ampliﬁcation (MDA) and custom primers that enables WGS of clinical specimens with very low genomic copies of T.
pallidum. We also investigated an alternative method, the NEBNext Microbiome DNA
enrichment kit, that uses CpG methylated capture of host DNA followed by MDA with
the REPLI-g single cell kit.
RESULTS
Real-time qPCR on clinical specimens and spiked samples. A total of 15 clinical
specimens were included in this study (Table 1). DNAs were extracted using standard
or large-scale extraction protocols, and T. pallidum gDNA (copies/m L of extract) was
estimated using quantitative PCR (qPCR) targeting the polA gene. As shown in Table 1,
3 specimens had .100 T. pallidum gDNA copies/m L and the remaining 12 specimens
had ,32 copies/m L. PCR ampliﬁcation of the human RNase P gene (RNP) was used to
estimate the concentration of human gDNA in each sample (28). RNP threshold cycle
(CT) values in the specimens ranged from 22.61 (highest concentration of RNP) to 38.32
(lowest concentration of RNP) (Table 1).
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TABLE 1 Clinical and laboratory data for specimens and the T. pallidum isolatea
Sample/
isolate IDb
CDC-SF003
EUHM-001
EUHM-002
EUHM-003
EUHM-004
EUHM-005
EUHM-006
EUHM-007
EUHM-008
EUHM-009
EUHM-010
EUHM-011
EUHM-012
EUHM-013
EUHM-014
STLC-001

Collection
yr
2017
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2020
2020
2020

Sexual
Gender orientationc
Male
MSM
Male
MSM
Male
MSM
Male
MSM
Male
MSM
Male
MSM
Male
MSM
Male
MSM
Male
MSM
Male
MSM
Male
MSM
Male
MSM
Male
MSM
Male
MSM
Male
MSM
Male
MSW

Syphilis
stage
Primary
Secondary
Secondary
Secondary
Primary
Secondary
Primary
Secondary
Secondary
Secondary
Secondary
Primary
Primary
Secondary
Secondary
Primary

Site of
lesion
Penis
Neck
Perianal
Penis
Penis
Penis
Penis
Hand
Scrotum
Scrotum
Scrotum
Penis
Penis
Penis
NA
Penis

Antibody
titer (assay)d
1:4 (VDRL)
1:128 (RPR)
1:256 (RPR)
1:32 (RPR)
1:4 (RPR)
1:64 (RPR)
1:16 (RPR)
1:64 (RPR)
1:64 (RPR)
1:64 (RPR)
1:128 (RPR)
1:32 (RPR)
1:8 (RPR)
1:64 (RPR)
1:16 (RPR)
NR (RPR)

qPCR (T. pallidum
gDNA in extract)
(copies/mL)
9,680
,1
,1
,1
106.7 6 6.5
,1
,1
,1
0.9 6 0.1
,1
,1
,1
31.5 6 0.5
122 6 1.2
103 6 6.7
28.8 6 3.1

RNPCT
NA
29.59 6 0.20
28.15 6 0.04
29.35 6 0.08
25.48 6 0.04
33.34 6 0.03
31.62 6 0.03
38.32 6 0.1
31.00 6 0.1
33.24 6 0.14
31.27 6 0.08
32.87 6 0.21
22.61 6 0.08
31.38 6 0.21
24.06 6 0.1
25.57 6 0.07

Extraction
method
Standard
Standard
Standard
Standard
Standard
Standard
Standard
Standard
Standard
Standard
Standard
Standard
Large scale
Large scale
Large scale
Standard

Reference
or source
11
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

aNA,

not available; NR, nonreactive.
Emory University Hospital, Atlanta, GA; STLC, St. Louis County STD Clinic, St. Louis. MO.
cMSM, men who have sex with men; MSW, men who have sex with women.
dVDRL, Venereal Disease Research Laboratory test; RPR, rapid plasma reagin test.

To determine the limit of detection (LoD) for each enrichment method, spiked samples were composed of a 10-fold dilution series of T. pallidum Nichols DNA against a
background of a constant concentration of human DNA. An RNPCT of 25.48, corresponding to the lowest CT value among specimens extracted with the standard protocol, was targeted as the cutoff for all the spiked samples. Based on qPCR, the copy
number of the undiluted spiked sample was estimated at 11,066.17 6 364.60 gDNA
copies/m L with an average RNPCT value of 25.07 6 0.04 (Table S1). The dilution series
generated from this spiked sample averaged 1,016 6 9.41 down to 1.57 6 0.12 T. pallidum gDNA copies/m L. The RNPCT values averaged 25.02 6 0.03 among all samples,
with no signiﬁcant difference observed among the RNPCT values for each dilution in
the series (P . 0.3; Table S1).
NEBNext microbiome enrichment with MDA. To determine the minimum T. pallidum copy number input required to generate adequate sequencing coverage, each
of the replicate 10-fold-diluted spiked samples were enriched with the New England
Biolabs (NEB) microbiome enrichment kit with subsequent REPLI-g single-cell MDA
(here referred to as NEB1MDA). We observed an increase in T. pallidum gDNA, determined by qPCR, in all spiked samples after enrichment (Fig. 1; Table S1). The enriched
spiked samples indicated an average of 6.67  106 6 2.74  105 to 964 6 574.23
gDNA copies/m L in the undiluted to 1:10,000 diluted samples, resulting in a 482 to
995.09 enrichment (Table S1). Upon comparing the average RNPCT of each dilution in
the series, the enriched samples indicated 29.28 6 1.07 to 31.42 6 0.45 for the neat
(undiluted) to 1:10,000 dilution (Table S1). The RNPCT values of each enriched sample in
the dilution series were not signiﬁcantly different from one another, with an average
RNPCT of 30.64 6 0.33 for all dilutions in the series (P = 0.22).
After enrichment with NEB1MDA, the average percentage of T. pallidum DNA in
the total DNA ranged from 2.33% 6 0.10 to 0.0004% 6 0.0003% for the neat to
1:10,000 dilution samples, resulting in up to a 26.12-fold increase in the percentage of
T. pallidum DNA among all enriched replicates (Fig. 2). Apart from enriched samples
from the 1:100 and 1:1,000 dilutions, we observed that increasing the T. pallidum input
gDNA copy number 10-fold resulted in a signiﬁcant increase in the total DNA belonging to T. pallidum postenrichment (P = 0.06 and P , 0.05, respectively).
To conﬁrm if the increase in T. pallidum gDNA copies correlated with the increase in genome coverage, sequencing data derived from samples enriched by NEB1MDA were
mapped against the T. pallidum Nichols reference genome (GenBank version number
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FIG 1 T. pallidum gDNA copies/m L for the 10-fold dilution series spiked samples enriched by the NEB1MDA or
SWGA. Spiked samples were composed of a 10-fold dilution series of T. pallidum Nichols DNA and a constant
concentration of human DNA. T. pallidum genome DNA (copies/m L of DNA extract) in samples pre- and
postenrichment was estimated using PCR targeting the polA gene and are shown in the bar graph. The y axis
has been log10-scaled for depiction of the nonenriched dilution series. Error bars represent the standard error
among three replicate enriched T. pallidum samples.

NC_021490.2). The genome sequencing data showed 0.01% to 10.52% of the quality-controlled reads binned as T. pallidum, along with a mean read mapping depth to the T. pallidum Nichols reference genome ranging from 0.51 to 501.75. An average percentage
coverage exceeding 97.29% across the Nichols reference genome with at least 5 reads
mapped per site (5) for the neat to 1:100 diluted samples, was observed among the
NEB1MDA enriched samples (Fig. 3A; Table S1 and Fig. S1). At the same time, for a higher
coverage of at least 10 reads mapped per nucleotide (10), the 1:100 diluted samples had
an average percentage coverage of 84.14%, while neat and 1:10 dilution samples covered
at 99.99% across the reference genome. A sharp decline in coverage was observed in the
enriched 1:1,000 and 1:10,000 diluted samples. With the quality control (QC) criteria for efﬁciency set at $90% at $5 read depth, samples sequenced post-NEB1MDA enrichment
had an LoD of 129 T. pallidum gDNA copies/m L (Fig. 3A; Table S1 and Fig. S1). A comparison of all the genome data generated from the serially diluted samples and the nonenriched T. pallidum Nichols control using the NEB1MDA protocol revealed no genetic variants, verifying that single nucleotide polymorphisms (SNPs), inversions, or deletions were
not introduced during whole-genome ampliﬁcation. NEB1MDA was subsequently used to
enrich CDC-SF003, a recently propagated clinical isolate (11), with 2.39  106 6 1.35  105
gDNA copies/m L of DNA extract observed postenrichment. We observed that 1.06% of the
total DNA belonged to T. pallidum postenrichment, and 3.29% of the host-removed quality-controlled sequencing reads were classiﬁed as T. pallidum. Sequencing indicated a
98.60% coverage across the T. pallidum SS14 reference genome (GenBank version number
NC_021508.1) at 5 read depth with a mean mapping depth of 46.43 (Fig. 4 and
Table 2; Fig. S2).
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SWGA enrichment of T. pallidum Nichols. While NEB1MDA was useful for enriching
samples with .129 T. pallidum gDNA copies/m L, we sought an alternative method for
enriching clinical specimens with lower T. pallidum gDNA copies (Table 1). Selective wholegenome ampliﬁcation (here referred to as SWGA) was chosen based on its success in other
bacteria (25–27). To determine an optimal primer set for enriching T. pallidum during SWGA,
a total of 12 primer sets were tested using Equiphi29 MDA (Thermo Fisher Scientiﬁc,
Waltham, MA; Tables S2 and S3) and the 1:100 diluted Nichols DNA sample (;129 gDNA
copies/m L) (Table S1; Table S4). The efﬁcacy of the SWGA primer sets varied, resulting in
DNA enrichment differences between 6.86 to 1.16  105 times (Fig. 5A) with 7 of the 12
primer sets (SWGA Pal 2, 4, 5, 9, 10, 11, and 12) and a .10,000-fold increase in gDNA copy
number. SWGA Pal 9 and Pal 11 gave the highest enrichment at 1.13  105 and 1.16  105
times, respectively (Table S4). The difference observed between Pal 9 and Pal 11 in the T.
pallidum gDNA copy number and relative percent DNA belonging to T. pallidum were not
signiﬁcantly different, and Pal 11 was selected for testing the SWGA limit of detection
(P . 0.1; Fig. 5; Table S4).
To determine the SWGA Pal 11 primer set’s LoD and enrichment for T. pallidum, SWGA
was performed in triplicate on the 10-fold dilution series, except for the neat sample. We
observed a marked increase in T. pallidum gDNA copy number in every dilution in the series postenrichment (Fig. 1; Table S1). The gDNA copy number ranged from 1.11  106 6
6.68  105 for the 1:10,000 dilution to 2.04  107 6 1.20  107 in the 1:10 dilution
(Table S1). Compared to the input copy number, this was a 2.01  104-fold to 5.53  105fold increase in the enriched samples, from 1:10 to 1:10,000 dilution, respectively. Upon
comparing the average RNPCT of each dilution in the series, the SWGA-enriched samples
indicated a 29.36 6 0.37 to 28.65 6 0.16 increase for the 1:10 to 1:10,000 dilution, respectively (Table S1). The average RNPCT values at each 10-fold increase in T. pallidum concentration were not signiﬁcantly different from one another (P . 0.1); however, by increasing
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FIG 2 Relative percent T. pallidum Nichols DNA in total DNA for nonenriched and NEB1MDA- and
SWGA-enriched spiked samples. Spiked samples were composed of a 10-fold dilution series of T.
pallidum Nichols DNA and a constant concentration of human DNA. The percent T. pallidum DNA in
total DNA was calculated based on the input DNA concentration and gDNA copies/m L (nonenriched)
and the DNA concentration and gDNA copies/m L for the Nichols-spiked samples postenrichment
(NEB1MDA or SWGA). Genome copies were estimated from measured T. pallidum polA copies/m L of
DNA extract. The y axis is log10-scaled for depiction of the nonenriched dilution series. Error bars
represent the standard error among three replicate samples.

mSphere

FIG 3 Percent coverage of sequencing reads of enriched T. pallidum Nichols spiked samples. Treponemal reads with at least
1 read mapped per site (1) against the T. pallidum subsp. pallidum Nichols reference genome (GenBank version number
NC_000919.1) and percent coverage of the T. pallidum genome are shown. (A) Sequencing reads of samples enriched using
the NEB1MDA method. (B) Sequencing reads of samples enriched using SWGA. All samples were sequenced using the
Illumina NovaSeq 6000 platform. Error bars represent the standard error between the mapped reads derived from three
replicate enriched Nichols samples.

the T. pallidum gDNA input 100-fold, we observed a signiﬁcant decrease in RNP concentration (P , 0.03).
After enrichment with SWGA, we observed that dilutions ranging from 1:10 to 1:10,000
held 27.93% 6 1.57% to 3.29% 6 1.93% of the total DNA belonging to T. pallidum, respectively (Fig. 2). This reﬂected up to a 1.63  105-fold increase in the relative T. pallidum
among all replicate SWGA-enriched samples compared to unenriched samples. All samples
were signiﬁcantly increased in their relative T. pallidum DNA compared to their respective
inputs (P , 0.0001). While there were observed deviations in the percent DNA between
replicates, the 1:10,000 diluted replicates still yielded a 28.40-fold 6 17.71-fold increase in
DNA belonging to T. pallidum post-SWGA compared to the nonenriched neat dilution
(P , 0.0001).
Genome sequencing data derived from the SWGA-enriched Nichols samples showed
0.98% to 78.05% of the quality-controlled reads binned as T. pallidum, along with a mean
mapping depth to the T. pallidum Nichols reference genome ranging from 65.82 to
4.89  103. An average percent coverage of 98.67% 6 0.005% for the 1:10 diluted samples
down to 96.15% 6 0.082% in the 1:1,000 diluted samples across the Nichols genome at 5
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read depth was observed among the SWGA-enriched samples. A sharp decline in coverage
was observed at the 1:10,000 dilution (Fig. 3B; Table S1 and Fig. S3). Comparing NEB1MDA
and SWGA for enrichment, we observed that SWGA consistently produced higher relative T.
pallidum DNA in all 10-fold diluted samples (P , 0.01). In addition, there was a sharp decline
in coverage observed in the 1:1,000 diluted samples enriched by NEB1MDA, while this
drop was not observed in samples enriched by SWGA, which still held .95% coverage at
5 read depth. As observed with NEB1MDA, no SNPs, inversions, or deletions were introduced during enrichment with SWGA. SWGA was subsequently used for enriching clinical
specimens in this study.
SWGA enrichment of clinical strains. SWGA on specimen EUHM-004 gave an average T. pallidum gDNA of 6.37  106 6 2.24  105 copies/m L, with 5.56% of the total
DNA belonging to T. pallidum (Table 2). Next-generation sequencing (NGS) on the
MiSeq v2 (500-cycle) platform revealed 95.13% coverage across the T. pallidum genome at 5 read depth (Fig. 4; Table 2 and Fig. S2). Due to the overall low copy number obtained by standard DNA extraction, three specimens (EUHM-012, EUHM-013,
and EUHM-014) were extracted using a large-scale method, yielding 31.5 6 0.5,
122 6 1.15, and 103 6 6.55 T. pallidum gDNA copies/m L of extract, respectively
(Table 1). For EUHM-012, we observed an average of 2.14  106 6 2.82  104 T. pallidum gDNA copies/m L, with 1.72% of the total DNA belonging to T. Pallidum postenrichment by SWGA (Table 2). Sequencing indicated a 93.98% coverage across the T.
pallidum genome at 5 read depth (Fig. 4; Table 2 and Fig. S2).
Compared to EUHM-012, EUHM-013 had a higher T. pallidum gDNA copy number/
m L at 5.16  106 6 2.20  105, with 15.48% of the total DNA belonging to T. pallidum
postenrichment by SWGA (Table 2). The sequencing data correlated with the qPCR
data, indicating a 98.56% coverage across the T. pallidum genome at 5 read depth
(Fig. 4 and Table 2; Fig. S2). We also observed that EUHM-014 held an increased T. pallidum gDNA copy number post-SWGA, with 2.57  106 6 2.21 105 copies/m L and
4.72% of the total DNA belonging to T. pallidum (Table 2). Upon sequencing, we
observed 98.49% coverage across the T. pallidum genome at 5 read depth (Fig. 4 and
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FIG 4 Percent coverage of a nonenriched T. pallidum Nichols isolate control containing 1,063.1 6 45.22 T. pallidum genomic
copies/m L of DNA extract, NEB1MDA-enriched clinical isolate CDC-SF003, and SWGA-enriched clinical specimens sequenced
using the Illumina MiSeq v2 (500- cycle) platform. The percentages of T. pallidum reads are derived from down-selected T.
pallidum reads. Preﬁltered reads for Nichols-CDC were mapped to the Nichols reference genome (GenBank version number
NC_000919.1). The preﬁltered reads in all clinical isolates and specimens were mapped against the SS14 reference genome
(GenBank version number NC_021508.1).
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SS14-like
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SS14-like
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Raw read
pairs
4,053,500
5,798,777
6,102,826
10,350,274
11,975,324
11,250,518
11,293,960

Nonhost
read pairs
3,645,649
3,988,173
4,440,618
5,870,287
11,966,460
9,266,926
7,770,834
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bNonenriched

sequencing was performed using Illumina’s MiSeq v2 (500 cycle) platform.
T. pallidum Nichols isolate used as MiSeq control.
cBased on T. pallidum polA calculated copies/m L.
dCalculated after quality assessment and T. pallidum selection of reads.

aAll

Sample
Nichols_CDCb
CDC-SF003
EUHM-004
EUHM-012
EUHM-013
EUHM-014
STLC-001

Enrichment
methoda
Nonenriched
NEB1MDA
SWGA
SWGA
SWGA
SWGA
SWGA

T. pallidum gDNA
copies/mL post
enrichmentc
1,063.1 6 45.22
2,394,930 6 135,210
6,367,089.5 6 240,811.5
2,140,753 6 28,192
5,159,716 6 220,318.5
2,573,508 6 221,900.5
7,420,534 6 719,765
Total read
pairs after QC
3,588,414
3,949,036
4,280,401
5,716,082
11,838,431
9,059,022
7,721,767

Read pairs
classiﬁed as
T. pallidum
70,299
129,998
1,403,645
2,793,693
8,308,234
2,355,426
3,004,631

Total read
pairs classiﬁed
as T. pallidum
(%)
1.96
3.29
32.79
48.87
70.18
26.00
38.91
Mean
read
depthd
6.33
46.44
370.39
639.86
2,503.96
930.87
1,133.43

TABLE 2 Sequencing percent coverage for the Nichols isolate, clinical isolate CDC-SF003, and clinical specimens across the T. pallidum reference genome
Genome
covered
‡1× (%)d
86.26
98.87
96.99
96.34
98.72
98.79
98.32

Genome
covered
‡5× (%)d
60.30
98.60
95.13
93.98
98.56
98.49
95.94

Genome
covered
‡10× (%)d
22.28
98.01
92.67
91.89
98.37
98.04
94.10
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FIG 5 SWGA primer set validation. (A) T. pallidum gDNA copies/m L for the Nichols spiked sample (1:100 diluted) enriched with
each SWGA primer set (1 to 12). (B) Relative percent T. pallidum DNA for the Nichols spiked sample (1:100 dilution) enriched with
each SWGA primer set. Percent T. pallidum DNA was calculated based on the input DNA concentration and gDNA copies/m L for
the Nichols mock samples post-SWGA enrichment. The spiked sample contained puriﬁed human gDNA, and the T. pallidum
genome copies were derived from qPCR-measured T. pallidum polA copies/m L of DNA extract. The input T. pallidum gDNA copies/
m L of DNA is displayed as nonenriched. The y axis is log10-scaled in each panel for depiction of the relative percent T. pallidum
post-enrichment with each primer set. Error bars represent the standard error among three replicate Nichols samples.

Table 2; Fig. S2). The T. pallidum gDNA copy number for specimen STLC-001 was
7.42  106 6 7.20  105 copies/m L, with 8.34% of the total DNA belonging to T. pallidum (Table 2). The sequencing coverage was 95.94% at 5 read depth, where 38.91%
of the quality-controlled reads binned as T. pallidum along with a mean read depth
coverage of 1,133.43 (Fig. 4 and Table 2; Fig. S2).
Phylogenetic analysis and characterization of genotypic macrolide resistance.
A whole-genome phylogenetic tree was constructed using the genomes derived from
the 5 clinical specimens and 2 isolates along with 126 high-quality published T. pallidum genome sequences as of May 2021 (18–21, 29–31; see Table S5). Phylogenetic
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FIG 6 Maximum likelihood global phylogenetic tree of the 7 T. pallidum strains sequenced in this study along with 122 high-quality (with 5 read depth
covering .90% of the genome) publicly available T. pallidum genomes. The two major lineages, Nichols-like and SS14-like, are highlighted along with the
presence of genotypic mutation responsible for macrolide resistance and country of origin.

analysis revealed the presence of two dominant lineages (Nichols-like and Street-14
[SS14]-like), of which most strains belonged to the SS14-like lineage. We identiﬁed a
total of four monophyletic clades within this phylogenetic tree with $30 bootstrap
support (Fig. 6). Three of the clinically derived genomes from Atlanta, Georgia, EUHM004 (2019) EUHM-012 (2019), and EUHM-014 (2020), belonged to the Nichols-like lineage (clade 1; n = 12; Fig. 6). Interestingly, the other nine Nichols-like genomes in clade
1 were recent clinically derived genomes from Cuba (n = 2; 2015 to 2016), Australia
(n = 1; 2014), France (n = 2; 2012 to 2013), and the United Kingdom (n = 3; 2016) and,
together with the specimens from Atlanta, were distinct from the original Nichols
strain isolated in 1912 and sent to different North American labs as in vivo-derived
clones. The three clinical specimens from Atlanta (EUHM-004, EUHM-012, and EUHM014) and three clinically derived genomes from the United Kingdom isolated in 2016
(NL14, NL19, and NL17) carried the 23S rRNA A2058G mutation, which confers macrolide resistance, suggesting a recent acquisition of this antibiotic resistance variant in
the Nichols-like lineage.
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DISCUSSION
WGS of T. pallidum is often challenging due to low bacterial loads or the difﬁculty of
obtaining adequate samples for testing. In this study, we sought to develop a method for
performing WGS from rabbit-propagated isolates and clinical specimens containing lower
T. pallidum numbers, leading us to investigate CpG capture and SWGA.
During the testing of the 10-fold dilution series of Nichols spiked samples, we
observed increases in T. pallidum gDNA copy numbers and relative T. pallidum percent
DNA in the neat to 1:1,000 dilutions enriched by NEB1MDA compared to the nonenriched inputs. There was no signiﬁcant difference in the relative human RNPCT from
dilution to dilution. While the neat to 1:100 dilution spiked samples demonstrated an
average percent coverage exceeding 97.29% at 5 read depth across the Nichols strain
genome, genomic coverage for 1:1,000 to 1:1,0000 diluted spiked samples was poor.
We observed that an input of .129 T. pallidum gDNA copies/m L can generate .95%
coverage at 5 read depth from the Nichols strain post-NEB1MDA enrichment. PostNEB1MDA enrichment of isolate CDC-SF003 demonstrated .98% coverage at 5
read depth across the T. pallidum genome. Variant analysis correlated with real-time
PCR detection of the mutations associated with macrolide resistance in CDC-SF003. In
addition, phylogenetics revealed that this strain belonged to the SS14 lineage, which
correlated with its enhanced CDC typing method (ECDCT) strain type, 14d9f, as previously reported (11). While this enrichment method yielded good results with isolates,
the fact that most clinical specimens collected in this study had fewer than 100 T. pallidum gDNA copies/m L extract led us to consider an alternative method.
We observed that samples enriched by SWGA using multiple primer sets exhibited
a 10,000-fold increase in T. pallidum genome copy number, with Pal 9 and 11 producing the highest relative percent T. pallidum DNA at 29% and 31%, respectively. While
we chose to work with Pal 11 as the optimal set, Pal 9 could also be a good alternative
for enriching syphilis specimens. Further testing using Pal 11 showed that the limit of
detection was increased compared to that of the T. pallidum enrichment obtained with
NEB1MDA, with signiﬁcant increases in both T. pallidum gDNA copy number and percent T. pallidum across the 10-fold dilution series of spiked samples. Coverage across
the T. pallidum genome exceeded 95% at 5 read depth for all diluted samples, apart
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Even though previous phylogenomic analyses indicated that the SS14-lineage
showed a polyphyletic structure, our phylogenetic analysis with a greater number of
genomes showed the presence of 3 monophyletic clades (clades 2, 3, and 4) (18, 20;
Fig. 6). Clades 2 and 4 contained genomes clustered within the previously reported
SS14X-A subcluster, which also contained two clades corresponding to the clades 2
and 4 detected in this study, and contained genomes derived from Europe and North
America, while clade 3 was like subcluster SS14X-B and composed of Chinese- and
North American-derived T. pallidum genomes (18). The rabbit-propagated isolate, CDCSF003 (San Francisco, USA; 2017) sequenced in this study clustered within clade 2,
while the EUHM-013 (Atlanta, USA; 2020) and STLC-001 (St. Louis, USA; 2020) genomes
clustered within clade 4. Sequence analysis showed that all 3 strains carried the
A2058G antimicrobial resistance variant for macrolide resistance. Macrolide resistance
strains were widespread among the SS14 lineage, with a higher proportion among the
genomes in clades 2 and 3 than those in clade 4 genomes. The A2058G point mutation
identiﬁed in 4 patient specimens and isolate CDC-SF003 was veriﬁed by real-time PCR
testing of gDNA and SWGA-enriched samples (data not shown). There was inadequate
sample of the ﬁfth specimen to conﬁrm the mutation by real-time PCR testing.
All the Nichols-like genomes derived from the NEB1MDA and SWGA 10-fold dilution
series that contained T. pallidum reads mapped to $90% of the genome with at least 5
read depth formed a tight monophyletic clade (bootstrap support of 88/100) and clustered
with the lab-derived Nichols-Houston-J genome (bootstrap support of 100/100), indicating
that genomes generated from both methods are adequate to capture genetic variants
required to perform a high-resolution phylogenetic analysis (Fig. S4).

mSphere

from the 1:10,000 diluted samples. Interestingly, we observed that increasing the T.
pallidum DNA input 100-fold resulted in a signiﬁcant decrease in the presence of RNP
postenrichment. Our data show that .14 T. pallidum gDNA copies/m L can generate at
least 95% coverage at 5 read depth with the Nichols strain using the SWGA enrichment method, which translated well to the clinical specimens tested. While there was a
decrease in coverage in one of the clinical specimens at 94.44% with 5 read depth
compared to the 98.62% coverage at 5 read depth observed in the 1:100 diluted
Nichols isolates, this could be primarily due to the improved capabilities of the
NovaSeq 6000 platform compared to the MiSeq v2 (500-cycle) platform used for
sequencing. Another possible reason for the variation in coverage could be the lower
T. pallidum input copy number in the clinical specimens.
The genomes derived directly from the 5 clinical specimens using SWGA were phylogenetically associated with the representative lineages (either Nichols-like or SS14like) and provided high levels of within-lineage strain resolution, which is ideal for
effective tracking of various strains circulating within a geographical area and outbreak
investigations. In addition, the NGS methods described here can be used for macrolide
resistance marker detection. As observed with NEB1MDA enrichment, azithromycin
mutation detection performed on the SWGA-enriched specimens matched the results
obtained by real-time PCR, indicating that all clinical specimens contained the A2058G
mutation. SWGA-based enrichment also enabled sequencing of specimens within the
range of detection limits for real-time PCR assays, suggesting that our NGS workﬂow
can be adapted for T. pallidum detection in metagenomic samples.
In terms of expense, both methods are cost-effective for enriching T. pallidum
gDNA, and while SWGA is less expensive than NEB1MDA, sequencing reagents are the
true limiting factor for WGS. With the recent advancements in large-scale sequencing
platforms, overall sequencing costs can be further reduced. While NovaSeq 6000 has a
much higher potential for multiplex sequencing, our data show compatibility of these
enrichments for both the NovaSeq 6000 and MiSeq platforms.
While we successfully enriched T. pallidum whole genomes in clinical specimens,
the success of SWGA is limited by the constraint on primer size, which may reduce the
selectivity for the target genome. Phi29 functions best between 30°C and 35°C, and
ramp-down incubations have been shown as an effective means of utilizing larger primers with increased melting temperatures (26, 27, 32, 33). To help alleviate the constraints on primer size, we utilized a thermostable phi29 mutant which has a much
higher optimal temperature at 45°C (34) compared to the 30°C to 35°C functional
range of the phi29 polymerase (26, 27). This higher optimal temperature permits the
use of longer oligonucleotides in the SWGA reaction, potentially increasing the selectivity for the T. pallidum genome. The phi29 mutant has also been shown to be more
efﬁcient, with a 3-h exhaustion time compared to the 8 to 16 h required for the wildtype phi29 (34). In addition, the genome sequence data generated from NEB1MDAand SWGA-enriched samples revealed that no SNPs, inversions, or deletions were introduced during whole-genome ampliﬁcation.
Our results show that SWGA is a more sensitive, less cumbersome, and faster
method for enriching clinical specimens compared to NEB1MDA, allowing for WGS of
T. pallidum with a minimum input of 14 gDNA copies/m L. In addition, the sequencing
data generated are of sufﬁcient quality to enable phylogenetic analyses and detection
of mutations associated with azithromycin resistance. While NEB1MDA was unsuitable
for the clinical specimens in this study, our data suggest that it can be used for DNA
extracts containing .129 T. pallidum gDNA copies/m L.
MATERIALS AND METHODS
Specimen collection, T. pallidum strains used for WGS, and real-time qPCR. Specimens used in
this study were collected from men presenting with lesions of primary or secondary syphilis to the
Emory Infectious Diseases Clinic, Emory University Hospital Midtown (EUHM) in Atlanta, GA, and the St.
Louis County STD Clinic (STLC) in St. Louis, MO (Table 1). Patients were diagnosed with syphilis based on
clinical presentation and serology testing. A total of 14 swab specimens were collected in Aptima
Multitest storage medium (Hologic, Inc., Marlborough, MA) at the Emory Infectious Diseases Clinic, and
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1 specimen was from the St. Louis County STD Clinic (Table 1). All specimens were stored at 280°C until
shipment on dry ice to the CDC. The T. pallidum Nichols reference strain was used for initial optimization
and validation of the two enrichment methods. A recent rabbit-propagated isolate, CDC-SF003, was also
included for testing (Table 1; 11). Prior to study commencement, local institutional review board (IRB)
approvals were obtained from Emory University and St. Louis County Department of Public Health, and
the project was approved at CDC.
DNA was extracted from specimens and rabbit testis extracts using the QIAamp DNA minikit (Qiagen,
Germantown, MD) following the manufacturer’s recommendations. To increase our chances of successfully
sequencing three specimens, large-scale DNA extraction was carried out on 1.5 mL of specimen using the
QIAamp DNA minikit with slight modiﬁcations for upscaling (Table 1). Brieﬂy, proteinase K was added at 0.1
total sample volume. AL buffer and ethanol were added at 1 total sample volume. Each sample was processed through a single column and eluted in 100 m L AE buffer (Qiagen). DNA samples were tested with a
real-time quantitative duplex PCR (qPCR) targeting the polA gene of T. pallidum and the human Rnase P
gene (RNP) using a Rotor-Gene 6000 instrument (Qiagen) as previously described with modiﬁcations (11, 28);
see (Text S1).
NEBNext microbiome enrichment and multiple displacement ampliﬁcation (MDA). Initially, DNA
concentrations of extracts from clinical specimens and rabbit-propagated strains were measured using the
Qubit double-stranded DNA (dsDNA) high-sensitivity (HS) assay (Thermo Fisher Scientiﬁc, Waltham, MA).
Capture and removal of CpG methylated host DNA from samples were carried out using the NEBNext microbiome DNA enrichment kit (New England Biolabs [NEB], Ipswich, MA), following the manufacturer’s recommendations with modiﬁcations (New England Biolabs). For all samples tested, 250 ng of DNA was subjected
to two rounds of bead capture using NEB and enriched treponemal gDNA was puriﬁed using AMPure XP
beads (Beckman Coulter, Indianapolis, IN). Enriched DNA samples were stored at 220°C until multiple displacement ampliﬁcation (MDA) was performed. MDA was carried out using the REPLI-g single cell kit following the manufacturer’s recommendations with slight modiﬁcations (Qiagen). MDA reaction mixtures were
incubated at 30°C for 16 h. Following ampliﬁcation, the polymerase was inactivated at 65°C for 10 min, and
samples were puriﬁed with AMPure XP beads and eluted with 100 m L 1 AE buffer (Qiagen). For enrichment
by MDA, no template controls were included to conﬁrm the absence of T. pallidum.
A 10-fold dilution series on the Nichols strain was used to determine the limit of detection (LoD) for
enrichment (see Text S1) with NEB1MDA followed by sequencing on an Illumina NovaSeq 6000 instrument.
After DNA extraction, each dilution in the series was enriched by NEB1MDA, gDNA copy numbers were estimated by polA qPCR, and sequencing was performed in triplicate. Enriched samples were diluted 1:10 prior
to measurement of RNP ampliﬁcation. The LoD was set at the minimum genome copy number required to
generate a $5 read depth with $95% genome coverage compared to the reference genome.
Selective whole-genome ampliﬁcation (SWGA) primer design, validation, and enrichment.
Primers with an increased afﬁnity to T. pallidum were identiﬁed using the swga toolkit as previously
described with slight modiﬁcations (https://www.github.com/eclarke/swga; 26; see Text S1). Eight
primer sets (SWGA Pal 1 to 8), and 4 additional primer sets (SWGA Pal 9 to 12) generated by combining
primers in the initial set (Table S1), were chosen for SWGA using EquiPhi29 DNA polymerase (Thermo
Fisher Scientiﬁc, Waltham, MA). To account for the 39–59 exonuclease activity of the phi29 polymerase,
all SWGA primers were generated with phosphorothioate bonds between the last two nucleotides at
the 39 end (Table S1). Each of the 12 primer sets was tested in triplicate against the spiked sample
diluted to an estimated 100 T. pallidum gDNA copies/m L (see Text S1).
Prior to SWGA enrichment, samples were denatured for 5 min at 95°C by adding 2.5 m L DNA to
2.5 m L reaction buffer, containing custom primers, and then placed immediately on ice until the
Equiphi29 master mix, prepared as per the manufacturer’s recommendations, was added. Whole-genome ampliﬁcation was carried out following the manufacturer’s recommendations with modiﬁcations
(Thermo Fisher Scientiﬁc; 34). The reaction contained EquiPhi29 master mix, with EquiPhi29 reaction
buffer at a ﬁnal concentration of 1, with each primer at a ﬁnal concentration of 4 m M, and nucleasefree H2O was added to a ﬁnal reaction volume of 20 m L. Reaction tubes were gently mixed by pulse vortexing and incubated at 45°C for 3 h. The reaction was stopped by inactivating the DNA polymerase at
65°C for 15 min. All reactions were puriﬁed using AMPure XP beads and eluted in 100 m L AE buffer
(Qiagen). No template controls were included to conﬁrm the absence of contaminate T. pallidum DNA.
The relative percent T. pallidum in each sample was calculated as shown in Fig. S1. SWGA Pal 11 was
chosen for testing the LoD for downstream genome sequencing post-SWGA enrichment using the 10fold dilution series, excluding the undiluted (neat) spiked sample. All enriched samples were validated
by polA real-time qPCR in triplicate.
Sequencing and genome analysis of T. pallidum strains. Libraries were prepared using the NEBNext
Ultra DNA library preparation kit for NovaSeq and the NEBNext Ultra II FS DNA library preparation kit for
MiSeq sequencing following the manufacturer’s recommendations (New England Biolabs, Ipswich, MA).
For the validation experiments, sequencing was carried out on the Nichols reference strain using the
NovaSeq 6000 platform following the manufacturer’s recommendations (Illumina, San Diego, CA).
Sequencing of isolate CDC-SF003 and swab specimens was carried out using the MiSeq v2 (500-cycle)
platform following the manufacturer’s recommendations (Illumina).
Sequenced genomic reads were ﬁrst ﬁltered from the raw sequencing data set using Bowtie 2 v2.2.9
(35), which removed any contaminating human sequences using the h19 human reference genome and
rabbit reference genome for rabbit-propagated clinical isolates (36). Cutadapt v1.8.3 was used to trim
speciﬁed primers and adaptors and to ﬁlter out reads below Phred quality scores of 15 and read lengths
below 50 bp (37). PCR duplicates were removed using Clumpify (sourceforge.net/projects/bbmap/) with
the dedupe=t option to prevent biased coverage of genomic regions. Treponemal reads were selected
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using K-SLAM, a k-mer-based metagenomics taxonomic proﬁler, which used a database containing all
bacterial and archaeal reference nucleotide sequences (38). The presence of T. pallidum sequences was
also conﬁrmed using MetaPhlan2 (39). Preﬁltered treponemal reads were mapped against either the T.
pallidum subsp. pallidum SS14 reference genome (GenBank version number NC_021508.1) or the T. pallidum subsp. pallidum Nichols reference genome (GenBank version number NC_000919.1) using the
Burrows-Wheeler Aligner MEM algorithm (BWA MEM) v2.12.0 (MapQ, $20), followed by consensus
sequence generation and estimation of sequencing depth and mapping statistics using SAMtools
(options “depth” and “mpileup”) and bcftools v1.9. The preﬁltered treponemal reads were also used to
generate de novo short-read assemblies using SPAdes v3.7.0 with the “careful” option (40–42).
To assess whether there were introductions of ampliﬁcation-induced SNPs, inversions, or deletions
for both NEB1MDA and SWGA, we compared the sequencing data generated from all three replicates
for each of the 10-fold dilution series for both protocols to the control genome generated directly from
an unampliﬁed DNA sample containing 10,000 gDNA copies/m L of T. pallidum Nichols. The same Nichols
DNA was used for the dilution series and the unampliﬁed sample. Essentially, the sequencing reads of
the Nichols control genome were de novo assembled using SPAdes v3.7.0 as described above, and the
resultant contigs were arranged using ABACAS in reference to the T. pallidum Nichols reference genome
(GenBank version number NC_021490.2) to generate a circular pseudochromosome (43). All T. pallidum
reads from all the NEB and SWGA 10-fold diluted samples were mapped against the control T. pallidum
Nichols pseudochromosome using Snippy v4.3.8 and checked for any genetic variants in the form of
SNPs, insertions, or deletions introduced during multiple ampliﬁcation steps.
Phylogenetic analyses. We used a reference mapping approach by mapping the ﬁltered treponemal reads to a custom version of the T. pallidum SS14 reference genome (GenBank version number NC
_021508.1) by masking around 30,000 nucleotide positions belonging to 12 repetitive tpr genes A to L,
along with arp and TPANIC_0470 genes using BEDTools v2.17.0 maskfasta (44). Full-length whole-genome alignment was generated using Snippy v4.3.8 (https://github.com/tseemann/snippy), which identiﬁes variants using FreeBayes v1.0.2 with a minimum 5 read coverage and 90% read concordance at a
locus for each SNP (45). Regions of increased density of homoplasious SNPs introduced by possible
recombination events were predicted iteratively and masked using Gubbins (46). The ﬁnal phylogenetic
tree was reconstructed using RAxML on the recombination-removed alignment using the GTR1GAMMA
model of nucleotide substitution with a majority-rule consensus (MRE) convergence criterion to reconstruct an ascertainment bias-corrected (Stamatakis method) maximum-likelihood (ML) phylogeny (47).
Apart from the genomes sequenced in this study, 126 high-quality (with at least 5 read depth covering .90% of the genome) T. pallidum genomes deposited in the NCBI Sequence Read Archive (SRA)
under BioProject numbers PRJEB20795 and PRJNA508872 were also included (18, 20). A second phylogenetic tree was also reconstructed by including all the genomes sequenced from the 10-fold dilution series for both NEB1MDA- and SWGA-enriched samples. Genomic sequencing data from samples included
in the phylogenetic analyses covered at least 90% of the reference genome with 5 read depth. Variant
calls for the A2058G and A2059G macrolide resistance mutations using genomic data were validated
with a previously described real-time PCR assay (5).
Statistical analyses. Statistical analyses were performed in R (R Foundation for Statistical Computing,
Vienna, Austria) using the R companion software RStudio (Boston, MA). Statistical signiﬁcance was determined
by analysis of variance (ANOVA) and Tukey post hoc multiple-comparison tests. T. pallidum percent DNA was
normalized through log10 conversions. Quantitative data are presented as means 6 standard error. Differences
were considered statistically signiﬁcant if P was ,0.05.
Data availability. All sequencing data associated with this study were submitted to the National Center
for Biotechnology Information Sequence Read Archive (SRA) under the BioProject number PRJNA744275.
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